aspirin has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| DeMeritt, IB; Nogalski, MT; Podduturi, JP; Tilley, AM; Yurochko, AD | 1 |
2 other study(ies) available for aspirin and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.
Topics: Aspirin; Cells, Cultured; Cytomegalovirus; Fibroblasts; Gene Expression Regulation, Viral; Humans; Leupeptins; NF-kappa B; Time Factors; Viral Proteins; Virus Replication | 2006 |